LONDON — AstraZeneca's AZN.L Fasenra, an injectable treatment for severe asthma, is more effective during attacks than the ...

Asthma affects more than 260M people worldwide and nearly 28M people in the U.S. alone, where, on average, 10 people die from attacks of the chronic disease each day.

It has shown efficacy in reducing asthma exacerbations, controlling symptoms, and decreasing systemic corticosteroid ...

Therefore, in the event of a negative result we should move to the next test in sequence. For the majority of people with ...

US FDA accepts GSK’s submission for the use of Nucala to treat patients with chronic obstructive pulmonary disease: London, UK Wednesday, December 11, 2024, 10:00 Hrs [IST] GSK ...

Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary ...

Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary ...

Researchers have found that an injection given during some asthma and Chronic Obstructive Pulmonary Disease (COPD) attacks reduces the need for further treatment by 30 per cent, which is more ...